|
|
Volumn 73, Issue 9, 2014, Pages 784-786
|
|
Implementation and use of biosimilars in the therapy of inflammatory rheumatic diseases: Statement of the German Society of Rheumatology;Einführung und Gebrauch von "biosimilars" in der Therapie entzündlich-rheumatischer Erkrankungen: Stellungnahme der Deutschen Gesellschaft für Rheumatologie
a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
BIOSIMILAR AGENT;
MONOCLONAL ANTIBODY;
ARTHRITIS, RHEUMATOID;
GERMANY;
HUMAN;
MEDICAL SOCIETY;
PRACTICE GUIDELINE;
RHEUMATOLOGY;
STANDARDS;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
BIOSIMILAR PHARMACEUTICALS;
GERMANY;
HUMANS;
PRACTICE GUIDELINES AS TOPIC;
RHEUMATOLOGY;
SOCIETIES, MEDICAL;
|
|
EID: 84923280531
PISSN: None
EISSN: 14351250
Source Type: Journal
DOI: 10.1007/s00393-014-1505-x Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|